Preliminary evaluation of the anticonvulsant activity of a valproic acid analog: N-(2-propylpentanoyl) urea

Research Communications in Molecular Pathology and Pharmacology

Volumn 97, Issue 2, 1997, Pages 151-164

  Tantisira, Boonyong ^a   Tantisira, Mayuree H ^a   Patarapanich, Chamnan ^a   Sooksawate, Thongchai ^a   Chunngam, Tipsuchon ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

N (2 PROPYLPENTANOYL)UREA; UNCLASSIFIED DRUG; VALPROIC ACID; VALPROIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; DRUG POTENCY; DRUG SAFETY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR DYSFUNCTION; MOUSE; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEIZURE;

ANIMALS; ANTICONVULSANTS; BICUCULLINE; CENTRAL NERVOUS SYSTEM; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; LETHAL DOSE 50; MALE; MICE; MOTOR ACTIVITY; PENTYLENETETRAZOLE; SEIZURES; SLEEP; STRYCHNINE; TIME FACTORS; UREA; VALPROIC ACID;

EID: 0030987512     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Browning, R.A. (1992). Overview of neurotransmission : Relationship to the action of antiepileptic drugs. In Drugs For Control Of Epilepsy. Faingold, C.L. and Fromm, G.H. (eds.). CRC Press, Boca Raton, FL. pp. 23-56.
2. Clark, C.R. (1988). Comparative anticonvulsant activity and neurotoxicity of 4-amino-n-(2, 6-dimethylphenyl) benzamide and prototype antiepileptic drugs in mice and rate. Epilepsia 29 : 198-203.
3. Dunham, N.W. and Miya, T.S. (1957). A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. 46 : 208-209.
4. Ferrendelli, J.A., Hooland, K.D., McKeon, A.C. and Covey, D.F. (1989). Comparison of the anticonvulsant activities of ethsuximide, valproate and a new anticonvulsant, thiobutyrolactone. Epilepsia 30 : 617-622.
5. Grant, S.M. and Fauld, D. (1992). Oxcarbazepine : A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorder. Drugs 43 : 873-888.
6. Krall, R.L., Penry, J.K., White, B.G., Kupferberg, H.J. and Swinyard, E.A. (1978). Antiepileptic drug development. II. Anticonvulsant drug screening. Epilepsia 19 : 409-428.
7. Lepptik, I.E. (1994). Antiepileptic drugs in development : Prospects for the near future. Epilepsia 35 (Suppl. 4) : S29-S40.
8. Litchfield, J.T. and Wilcoxon, F.W. (1949). A simplified method of evaluating dose effect experiments. J. Pharmacol. Exp. Ther. 96 : 99-119.
9. Loscher, W., Honack, D., Fassbender, C.P. and Nolting, B. (1991). The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res. 8 : 171-189.
10. Loscher, W. and Nolting, B. (1991). The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices. Epilepsy Res. 9:1-10.
11. Porter, R.J. and Rogawski, M.A. (1992). New antiepileptic drugs : From serendipity to rational discovery. Epilepsia 33 (Suppl. 1) : S1-S6.
12. Rogawski, M.A. and Porter, R.J. (1990). Antiepileptic drug : Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42 : 223-286.
13. Saisorn, B., Patarapanich, C. and Janwitayanuchit, W. (1992). Synthesis of monoureide analogs of valproic acid. Thai J. Pharm. Sci. 16 (2) : 145-150.
14. nd ed., Woodbury, D.M., Penry, J.K. and Pippenger, C.E. (eds.). PP. 111-140.
15. Thompson, E.B. (1990). Drug bioscreening. In Drug evaluation techniques in pharmacology. New York; VCH publisher, PP. 3-32.
16. Ticku, M.K and Rastogi, R.K. (1986). Convulsant/anticonvulsant drugs and GABA ergic transmission. In Neurotransmitter, seizure and epilepsy III. Nistico, G., Morselli, P.L., Lloyd, K.G., Fariello, R.G. and Engel, J. (eds). New York : Raven Press, PP. 163-176.
17. Walker, R.M., Smith, G.S., Basoun, N.J. and Macallan, G.E. (1990). Pre-clinical toxicity of the anticonvulsant calcium valproate. Toxicology 63 : 137-155.